New investments
Colin Kerr
Published: Friday, September 13, 2019
VSY Biotechnology say the company has made new investments in order to make the supply chain network faster and more efficient in Germany.
Mrs Özge Altunbaş Göktekin, the CEO of VSY Biotechnology said :
“In the global world, we are developing our networks to establish close relationships with our customers all over the world, regardless of geographical differences, using technology and logistics centers. The structure of our distribution networks integrates with technology. As an international company we export to about 60 countries. In line with our sustainable growth, we are improving our supply chain and logistics activities with each passing day.
We set up both our new ordering system and our new logistics center in line with our aim to reach our customers in Europe much faster and deliver the products they want. We are increasing our speed in Europe with our new logistics center and online ordering system in Germany.
Our European customers, who demand products from VSY Biotechnology, can instantly access orders on digital media and receive products in a very short time. We are working to maximize customer satisfaction with our innovative products and high-quality services, ” said Mrs Göktekin.
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.